Skip to main content
Erschienen in: Archives of Dermatological Research 10/2012

01.12.2012 | Original Paper

Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study

verfasst von: Enayat Attwa, Hend Gamil, Magda Assaf, Sohair Ghonemy

Erschienen in: Archives of Dermatological Research | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

There is a growing evidence that cytokines are important in the depigmentation process of vitiligo, however, the exact mechanism is not fully understood. The aim of this work was to study the possible role of the tumor necrosis factor-α (TNF-α) cytokine in the depigmentation process of the disease. Twenty patients with generalized vitiligo were exposed to narrow-band ultraviolet B (NB-UVB) therapy thrice weekly for a total of 60 sessions. Immunohistochemical examination was done, to assess the TNF-α expression in lesional and perilesional skin as compared to normal control skin, before and after therapy. At baseline, positive lesional TNF-α expression was detected in 60 % of patients which was significantly higher as compared to perilesional skin (20 %) and negative expression in healthy control skin. Post-treatment, a statistically significant increase in TNF-α expression was detected in both lesional (90 %) and perilesional skin (70 %) as compared to baseline (P < 0.05). The significant increase of TNF-α in vitiligo lesions compared with perilesional and healthy skin suggests a possible involvement of this cytokine in the depigmentation of vitiligo. The increase in TNF-α expression after NB-UVB phototherapy suggests another role in repigmentation.
Literatur
1.
Zurück zum Zitat Arca E, Tastan HB, Erbil AH et al (2006) Narrow band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 33:338–343PubMedCrossRef Arca E, Tastan HB, Erbil AH et al (2006) Narrow band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 33:338–343PubMedCrossRef
2.
Zurück zum Zitat Birol A, Kisa U, Kurtipek GS et al (2006) Increased tumour necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL-1α) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol 45:992–993PubMedCrossRef Birol A, Kisa U, Kurtipek GS et al (2006) Increased tumour necrosis factor alpha (TNF-α) and interleukin 1 alpha (IL-1α) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol 45:992–993PubMedCrossRef
3.
Zurück zum Zitat Brazzelli V, Antoninetti M, Palazzini S et al (2007) Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with NB-UVB phototherapy. J Eur Acad Dermatol Venereol 21:1369–1374PubMedCrossRef Brazzelli V, Antoninetti M, Palazzini S et al (2007) Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with NB-UVB phototherapy. J Eur Acad Dermatol Venereol 21:1369–1374PubMedCrossRef
4.
Zurück zum Zitat Brink N, Szamel M, Young AR et al (2000) Comparative quantification of IL-1β, IL-10, TNF-α and IL-7 mRNA levels in UV irradiated skin in vivo. Inflamm Res 49:290–296PubMedCrossRef Brink N, Szamel M, Young AR et al (2000) Comparative quantification of IL-1β, IL-10, TNF-α and IL-7 mRNA levels in UV irradiated skin in vivo. Inflamm Res 49:290–296PubMedCrossRef
5.
Zurück zum Zitat Cui J, Shen LY, Wang GC (1991) Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 97:410–416PubMedCrossRef Cui J, Shen LY, Wang GC (1991) Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 97:410–416PubMedCrossRef
6.
Zurück zum Zitat Eves PC, Bullett NA, Haddow D et al (2008) Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J Invest Dermatol 128(6):1554–1564PubMedCrossRef Eves PC, Bullett NA, Haddow D et al (2008) Simplifying the delivery of melanocytes and keratinocytes for the treatment of vitiligo using a chemically defined carrier dressing. J Invest Dermatol 128(6):1554–1564PubMedCrossRef
7.
8.
Zurück zum Zitat Goktas EO, Aydin F, Senturk N et al (2006) Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 20:553–557PubMedCrossRef Goktas EO, Aydin F, Senturk N et al (2006) Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J Eur Acad Dermatol Venereol 20:553–557PubMedCrossRef
9.
Zurück zum Zitat Grimes PE, Morris R, Avaniss-Aghajani T et al (2004) Topical tacrolimus therapy for vitiligo. Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51(1):52–61PubMedCrossRef Grimes PE, Morris R, Avaniss-Aghajani T et al (2004) Topical tacrolimus therapy for vitiligo. Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 51(1):52–61PubMedCrossRef
10.
Zurück zum Zitat Hamzavi I, Jain H, McLean D et al (2004) Parametric modeling of narrow band UV-B phototherapy for vitiligo using a novel quantitative tool. Arch Dermatol 140:677–683PubMedCrossRef Hamzavi I, Jain H, McLean D et al (2004) Parametric modeling of narrow band UV-B phototherapy for vitiligo using a novel quantitative tool. Arch Dermatol 140:677–683PubMedCrossRef
11.
Zurück zum Zitat Hino R, Kobayashi T, Mori H et al (2007) Inhibition of T helper 2 chemokine production by narrow-band ultraviolet B in cultured keratinocytes. Br J Dermatol 156:830–837PubMedCrossRef Hino R, Kobayashi T, Mori H et al (2007) Inhibition of T helper 2 chemokine production by narrow-band ultraviolet B in cultured keratinocytes. Br J Dermatol 156:830–837PubMedCrossRef
12.
Zurück zum Zitat Joshi PG, Nair N, Begum G et al (2007) Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res 20(5):380–384PubMed Joshi PG, Nair N, Begum G et al (2007) Melanocyte-keratinocyte interaction induces calcium signalling and melanin transfer to keratinocytes. Pigment Cell Res 20(5):380–384PubMed
13.
Zurück zum Zitat Kang HY, Kang WH (2004) Leukomelanoderma following acute cutaneous graft-versus-host disease. Eur J Dermatol 14(3):146–149PubMed Kang HY, Kang WH (2004) Leukomelanoderma following acute cutaneous graft-versus-host disease. Eur J Dermatol 14(3):146–149PubMed
14.
Zurück zum Zitat Kawaguchi M, Mitsuhashi Y, Kondo S (2005) Over expression of tumor necrosis factor α-converting enzyme in psoriasis. Br J Dermatol 152(5):915–919PubMedCrossRef Kawaguchi M, Mitsuhashi Y, Kondo S (2005) Over expression of tumor necrosis factor α-converting enzyme in psoriasis. Br J Dermatol 152(5):915–919PubMedCrossRef
15.
Zurück zum Zitat Köck A, Shwarz T, Kirnbauer R et al (1990) Human keratinocytes are a source for tumour necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614PubMedCrossRef Köck A, Shwarz T, Kirnbauer R et al (1990) Human keratinocytes are a source for tumour necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614PubMedCrossRef
16.
Zurück zum Zitat Leverkus M, Yaar M, Eller MS et al (1998) Post transcriptional regulation of UV induced TNF-alpha expression. J Invest Dermatol 110:353–357PubMedCrossRef Leverkus M, Yaar M, Eller MS et al (1998) Post transcriptional regulation of UV induced TNF-alpha expression. J Invest Dermatol 110:353–357PubMedCrossRef
17.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275PubMed
18.
Zurück zum Zitat Martinez-Esparzo M, Jimenez-Cervantes C, Solano F et al (1998) Mechanisms of melanogenesis inhibition by tumour necrosis factor-α in melanoma cells. Eur J Biochem 255:139–146CrossRef Martinez-Esparzo M, Jimenez-Cervantes C, Solano F et al (1998) Mechanisms of melanogenesis inhibition by tumour necrosis factor-α in melanoma cells. Eur J Biochem 255:139–146CrossRef
19.
Zurück zum Zitat Moretti S, Spallanzani A, Amato L et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87–92PubMedCrossRef Moretti S, Spallanzani A, Amato L et al (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15:87–92PubMedCrossRef
20.
Zurück zum Zitat Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42:245–253PubMedCrossRef Njoo MD, Bos JD, Westerhof W (2000) Treatment of generalized vitiligo in children with narrow band (TL-01) UVB radiation therapy. J Am Acad Dermatol 42:245–253PubMedCrossRef
21.
Zurück zum Zitat Scherschun L, Kim JJ, Lim HW (2001) Narrow band ultraviolet-B is a useful and well tolerated treatment for vitiligo. J Am Acad Dermatol 44(6):999–1003PubMedCrossRef Scherschun L, Kim JJ, Lim HW (2001) Narrow band ultraviolet-B is a useful and well tolerated treatment for vitiligo. J Am Acad Dermatol 44(6):999–1003PubMedCrossRef
22.
Zurück zum Zitat Schwarz A, Maeda A, Wild MK et al (2004) Ultraviolet radiation induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172:1036–1043PubMed Schwarz A, Maeda A, Wild MK et al (2004) Ultraviolet radiation induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172:1036–1043PubMed
23.
24.
Zurück zum Zitat Seité S, Colige A, Deroanne C et al (2004) Changes in matrix gene and protein expressions after single or repeated exposure to one minimal erythemal dose of solar-stimulated radiation in human skin in vivo. Photochem Photobiol 79:265–271PubMedCrossRef Seité S, Colige A, Deroanne C et al (2004) Changes in matrix gene and protein expressions after single or repeated exposure to one minimal erythemal dose of solar-stimulated radiation in human skin in vivo. Photochem Photobiol 79:265–271PubMedCrossRef
25.
Zurück zum Zitat Shang J, Eberle J, Geilen CC et al (2002) The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induce. Skin Pharmacol Appl Skin Physiol 15:321–329PubMedCrossRef Shang J, Eberle J, Geilen CC et al (2002) The role of nuclear factor-kappa B and melanogenesis in tumor necrosis factor-alpha-induce. Skin Pharmacol Appl Skin Physiol 15:321–329PubMedCrossRef
26.
Zurück zum Zitat Shintani Y, Yasuda Y, Kobayashi K et al (2008) Narrow band UVB radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed 24:32–37PubMedCrossRef Shintani Y, Yasuda Y, Kobayashi K et al (2008) Narrow band UVB radiation suppresses contact hypersensitivity. Photodermatol Photoimmunol Photomed 24:32–37PubMedCrossRef
27.
Zurück zum Zitat Skov L, Hansen H, Allen M et al (1998) Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor alpha in human skin. Br J Dermatol 138:216–220PubMedCrossRef Skov L, Hansen H, Allen M et al (1998) Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor alpha in human skin. Br J Dermatol 138:216–220PubMedCrossRef
28.
Zurück zum Zitat Wallace ML, Smoller BR (1996) Immunohistochemistry in diagnostic dermatopathology. J Am Acad Dermatol 34(2):163–183PubMedCrossRef Wallace ML, Smoller BR (1996) Immunohistochemistry in diagnostic dermatopathology. J Am Acad Dermatol 34(2):163–183PubMedCrossRef
29.
Zurück zum Zitat Westerhof W, d’ Ischia M (2007) Vitiligo puzzle, the pieces fall in place. Pigment Cell Res 20(5):345–359PubMed Westerhof W, d’ Ischia M (2007) Vitiligo puzzle, the pieces fall in place. Pigment Cell Res 20(5):345–359PubMed
Metadaten
Titel
Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study
verfasst von
Enayat Attwa
Hend Gamil
Magda Assaf
Sohair Ghonemy
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 10/2012
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-012-1269-6

Weitere Artikel der Ausgabe 10/2012

Archives of Dermatological Research 10/2012 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.